For people diagnosed with advanced pancreatic cancer, the outlook is about as grim as it gets: the average patient won’t live longer than a year. But a new study involving a targeted drug therapy has demonstrated it may be possible to significantly slow its spread, with a third of patients receiving the medication still alive two years into a clinical […]

Continue reading »